Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma. - Nicolson NG; Tandurella JA; Wu LW; Patel J; Morris E; Seppälä TT; Guinn S; Zlomke H; Shubert CR; Lafaro KJ; Burns WR; Cameron JL; et al. (Annals of surgery, 2026)